Ipsen SA.

Отворен

СекторФинансови

165.5 2.1

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

160.1

Максимум

162.5

Ключови измерители

By Trading Economics

Приходи

294M

403M

Продажби

334M

2.2B

P/E

Средно за сектора

26.133

22.368

Дивидентна доходност

1.03

Марж на печалбата

18.405

Служители

5,535

EBITDA

556M

1B

Препоръки

By TipRanks

Препоръки

Неутрален

12-месечна прогноза

+8.63% upside

Дивиденти

By Acuity

Дивидентна доходност

Средно за сектора

1.03%

4.40%

Пазарни показатели

By TradingEconomics

Пазарна капитализация

224M

13B

Предишно отваряне

163.4

Предишно затваряне

165.5

Настроения в новините

By Acuity

7%

93%

8 / 436 Класиране в Finance

Ipsen SA. Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

24.08.2026 г., 23:46 ч. UTC

News

PG&E Corp shares are lower in after-market hours despite announcing an expansion of its Vehicle to Everything program and analysts' fair value estimate of $22.59.

24.08.2026 г., 23:46 ч. UTC

News

DA Davidson initiated coverage of Vulcan Materials Co with a Buy rating. Shares traded higher in after-market hours following Monday's close of $276.04.

24.08.2026 г., 23:46 ч. UTC

News

Jack Henry & Associates appoints Richard N. Preece to its Board of Directors, effective August 20, 2026. Shares are higher in after-market trading.

24.08.2026 г., 23:46 ч. UTC

News

Parker-Hannifin Corp filed a mixed securities shelf to raise capital. Shares advanced in after-market trading, continuing a trend of higher daily closes.

24.08.2026 г., 23:31 ч. UTC

News
Social Media

Kura Oncology shares are higher in after-market hours following CEO Troy Wilson's $1.2 million stock purchase, boosting his ownership to 1.214 million shares.

24.08.2026 г., 23:26 ч. UTC

News

National Beverage Corp's shares are lower in after-market hours, despite recent strength and five consecutive higher closes, amid geopolitical concerns affecting market sentiment.

24.08.2026 г., 23:21 ч. UTC

News

USD/HKD is trading lower, impacted by a stronger U.S. Dollar and economic pressures from new sanctions on Iran. Limited fluctuations persist in the market.

24.08.2026 г., 23:16 ч. UTC

News

Trade Desk Inc's stock fell in after-hours trading following a prospectus filing for a mixed shelf offering of various securities. The company holds $1.12 billion in cash.

24.08.2026 г., 23:16 ч. UTC

News

Coinbase Global Inc shares declined in after-market trading following the company's integration of Chainlink for real-time pricing of tokenized stocks on Base.

24.08.2026 г., 23:16 ч. UTC

News

Diamondback Energy shares are lower in after-market hours amid concerns from CEO Van't Hof's recent insider selling of 10,000 shares at $214.66 each.

24.08.2026 г., 23:11 ч. UTC

News

Nasdaq Inc shares are trading lower in after-market hours, reflecting broader market declines driven by weakness in technology stocks and geopolitical tensions.

24.08.2026 г., 23:11 ч. UTC

News

Copart Inc shares are lower in after-market hours, reflecting unusual volatility amid broader market concerns over geopolitical tensions and economic disruptions.

24.08.2026 г., 23:06 ч. UTC

Event
News

Gilead Sciences gains after European approval for Trodelvy and raises 2026 sales guidance to $30.1–$30.4 billion, reflecting strong performance in HIV and oncology.

24.08.2026 г., 23:01 ч. UTC

Social Media
News

Re/Max Holdings Inc. announced a $450 million share repurchase authorization, contributing to a higher trading performance during after-market hours.

24.08.2026 г., 23:01 ч. UTC

News

Grand Canyon Education shares declined in after-market hours following CFO Daniel E. Bachus's placement on paid administrative leave amid an ongoing investigation.

24.08.2026 г., 23:01 ч. UTC

News

Herc Holdings shares rise in after-market trading following director Erik Olsson's $503K purchase of 3.1K shares, signaling potential confidence in the company.

24.08.2026 г., 23:01 ч. UTC

News

Tyson Foods announced a $1 million commitment to the Harvest to Hallways initiative, enhancing childhood nutrition and food access, contributing to positive sentiment.

24.08.2026 г., 23:01 ч. UTC

News

Oshkosh shares are higher in after-market trading following praise from Secretary of War Pete Hegseth for the company's defense manufacturing capabilities and tactical vehicles.

24.08.2026 г., 23:01 ч. UTC

News

Vistra Corp shares rose in after-market trading after CEO James Burke bought 2,000 shares for $270,000, increasing his total ownership to 1.235 million shares.

24.08.2026 г., 22:51 ч. UTC

News
Social Media

Boeing Co received a $131.23 billion contract for the F-15 Eagle Crest, with shares trading higher in after-market hours following the announcement.

24.08.2026 г., 22:16 ч. UTC

News

A federal court upheld an $83.4 million award against Guardant Health for patent infringement, though shares are trading higher in after-market hours.

24.08.2026 г., 22:16 ч. UTC

News

Kenneth S. Courtis bought $3.2 million in Alpha Metallurgical Resources shares, contributing to modest after-market gains following recent insider purchases.

24.08.2026 г., 22:06 ч. UTC

News

Peabody Energy shares are lower in after-market hours following a class action lawsuit alleging misleading statements about its Centurion mine operations.

24.08.2026 г., 22:01 ч. UTC

News

Savara Inc. will present Phase 3 trial results for molgramostim at the European Respiratory Society Congress in 2026. Shares are higher in after-market trading.

24.08.2026 г., 21:41 ч. UTC

News

Franklin Resources announces cash distributions for ETFs, with payments set for September 2026. Shares are trading higher in after-market hours following the news.

24.08.2026 г., 21:02 ч. UTC

News

DA Davidson initiated coverage of Advanced Drainage Systems with a Buy rating. Shares rose in after-market trading, closing at $143.73.

24.08.2026 г., 21:01 ч. UTC

News

Owens Corning shares rise in after-market trading following a Buy rating from DA Davidson analyst Garik Shmois. The stock closed at $148.06.

24.08.2026 г., 20:07 ч. UTC

Social Media
News

Uber Technologies has partnered with Zoomcar to offer intercity ride options in India. Shares are higher as the initiative launches in major cities.

24.08.2026 г., 20:07 ч. UTC

News
Correlated Moves
Social Media

NVIDIA Corp's stock is lower amid negative sentiment from a senior manager's indictment for alleged AI chip smuggling and rising costs for customers.

24.08.2026 г., 20:07 ч. UTC

News

Impinj Inc shares are lower amid pressure in the Semiconductors sector and concerns over licensing revenue from NXP. Adjusted EBITDA margin is 15%.

Сравнение с други в отрасъла

Ценова промяна

Ipsen SA. Прогноза

Ценова цел

By TipRanks

8.63% нагоре

12-месечна прогноза

Среден 177.5 EUR  8.63%

Висок 235 EUR

Нисък 135 EUR

Според 5 анализатори от Wall Street, предложили 12-месечна ценова цел за Ipsen SA. през последните три месеца.

Консенсусна оценка

By TipRanks

Неутрален

5 ratings

1

Купи

3

Задържане

1

Продай

Настроение

By Acuity

8 / 436 Класиране в Финансови

Настроения в новините

Много силни бичи доказателства

Волатилност

Под средното

Обем новини (RCV)

Под средното

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

$

Относно Ipsen SA.

Ipsen S.A. operates as a biopharmaceutical company worldwide. The company provides drugs in the areas of oncology, neuroscience, and rare diseases. Its product pipeline comprises Cabometyx + Atezolizumab, which is in phase III clinical trial for the treatment of second line metastatic castration-resistant prostate cancer; lenalidomide and rituximab, and Taverik, which is in phase III for the treatment of second line follicular lymphoma; Bylvay, which is in phase III for the treatment of biliary atresia; Dysport, which is in phase III clinical trial for the treatment of chronic and episodic migraine; Fidrisertib, which is in phase II clinical trial for the treatment of fibrodysplasia ossificans progressiva; Elafibranor, which is in phase II for the treatment of primary sclerosing cholangitis, as well as IPN60250; IPN10200, which is in phase II for the treatment of longer-acting neurotoxin aesthetics and therapeutics; IPN60210, which is in phase I clinical trial for the treatment of relapsed/refractory multiple myeloma; and IPN60260 for the treatment of Viral cholestatic disease and is in phase I clinical trial. The company also offers Somatuline, Decapeptyl, Cabometyx, Onivyde, Tazverik, and other oncology products; Dysport and other neurosciences products; and Bylvay, NutropinAq, Increlex, and Sohonos for rare diseases. The company was founded in 1929 and is based in Boulogne-Billancourt, France.
help-icon Live chat